Influence of body mass index on psychological and functional outcomes in patients with multiple sclerosis: a cross-sectional study

References

• Khurana SR, Bamer AM, Turner AP, Wadhwani RV, Bowen JD, Leipertz SL, et al. The prevalence of overweight and obesity in veterans with multiple sclerosis. Am J Phys Med Rehabil 2009;88:83–91. doi: 10.1097/PHM.0b013e318194f8b5
   PubMed Web of Science ®Google Scholar
• Marrie RA, Horwitz R, Cutter G, Tyry T, Campagnolo D, Vollmer T. High frequency of adverse health behaviors in multiple sclerosis. Mult Scler 2009;15:105–13. doi: 10.1177/1352458508096680
   PubMed Web of Science ®Google Scholar
• Pilutti LA, Dlugonski D, Pula JH, Motl RW. Weight status in persons with multiple sclerosis: implications for mobility outcomes. J Obes 2012;2012:868256. doi: 10.1155/2012/868256
   PubMedGoogle Scholar
• Langer-Gould A, Brara SM, Beaber BE, Koebnick C. Childhood obesity and risk of pediatric multiple sclerosis and clinically isolated syndrome. Neurology 2013;80:548–52. doi: 10.1212/WNL.0b013e31828154f3
   PubMed Web of Science ®Google Scholar
• Hedström AK, Olsson T, Alfredsson L. High body mass index before age 20 is associated with increased risk for multiple sclerosis in both men and women. Mult Scler 2012;18:1334–36. doi: 10.1177/1352458512436596
   PubMed Web of Science ®Google Scholar
• Lee EB, Mattson MP. The neuropathology of obesity: insights from human disease. Acta Neuropathol 2014;127:3–28. doi: 10.1007/s00401-013-1190-x
   PubMed Web of Science ®Google Scholar
• Schwarz S, Leweling H. Multiple sclerosis and nutrition. Mult Scler 2005;11:24–32. doi: 10.1191/1352458505ms1119oa
   PubMed Web of Science ®Google Scholar
• Benedict RHB, Priore RL, Miller C, Munschauer F, Jacobs L. Personality disorder in multiple sclerosis correlates with cognitive impairment. J Neuropsychiatry Clin Neurosci 2001;13:70–76. doi: 10.1176/jnp.13.1.70
   PubMed Web of Science ®Google Scholar
• Fishman I, Benedict RHB, Bakshi R, Priore R, Weinstock-Guttman B. Construct validity and frequency of euphoria sclerotica in multiple sclerosis. J Neuropsychiatry Clin Neurosci 2004;16:350–56. doi: 10.1176/jnp.16.3.350
   PubMed Web of Science ®Google Scholar
• Jopson NM, Moss-Morris R. The role of illness severity and illness representations in adjusting to multiple sclerosis. J Psychosom Res 2003;54:503–11. doi: 10.1016/S0022-3999(02)00455-5
   PubMed Web of Science ®Google Scholar
• Volery M, Carrard I, Rouget P, Archinard M, Golay A. Cognitive distorsions in obese patients with or without eating disorders. Eat Weight Disord 2006;11:123–26. doi: 10.1007/BF03327577
   PubMedGoogle Scholar
• Nagaraj K, Taly AB, Gupta A, Prasad C, Christopher R. Depression and sleep disturbances in patients with multiple sclerosis and correlation with associated fatigue. J Neurosci Rural Pract 2013;4:387–91. doi: 10.4103/0976-3147.120201
   PubMedGoogle Scholar
• Janssens AC, van Doorn PA, de Boer JB, Kalkers NF, van der Meche FG, Passchier J, et al. Anxiety and depression influence the relation between disability status and quality of life in multiple sclerosis. Mult Scler 2003;9:397–403. doi: 10.1191/1352458503ms930oa
   PubMed Web of Science ®Google Scholar
• Dahl OP, Stordal E, Lydersen S, Midgard R. Anxiety and depression in multiple sclerosis: a comparative population-based study in Nord-Trøndelag County, Norway. Mult Scler 2009;15:1495–501. doi: 10.1177/1352458509351542
   PubMed Web of Science ®Google Scholar
• Marmorstein NR, Iacono WG, Legrand L. Obesity and depression in adolescence and beyond: reciprocal risks. Int J Obes. 2014;38:906–11.
   Web of Science ®Google Scholar
• Simon GE, von Korff M, Saunders K, Miglioretti DL, Crane PK, van Belle G. Association between obesity and psychiatric disorders in the US adult population. Arch Gen Psychiatry 2006;63:824–30. doi: 10.1001/archpsyc.63.7.824
   PubMed Web of Science ®Google Scholar
• Faith MS, Butryn M, Wadden TA, Fabricatore A, Nguyen AM, Heymsfield SB. Evidence for prospective associations among depression and obesity in population-based studies. Obes Rev 2011;12:e438–53. doi: 10.1111/j.1467-789X.2010.00843.x
   PubMed Web of Science ®Google Scholar
• Browning RC, Baker EA, Herron JA, Kram R. Effects of obesity and sex on the energetic cost and preferred speed of walking. J Appl Physiol 2006;100:390–98. doi: 10.1152/japplphysiol.00767.2005
   PubMed Web of Science ®Google Scholar
• Lai PP, Leung AK, Li AN, Zhang M. Three-dimensional gait analysis of obese adults. Clin Biomech 2008;23:S2–S6. doi: 10.1016/j.clinbiomech.2008.02.004
   PubMed Web of Science ®Google Scholar
• Pearson OR, Busse ME, van Deursen RWM, Wiles CM. Quantification of walking mobility in neurological disorders. QJM 2009;97:463–75. doi: 10.1093/qjmed/hch084
   Web of Science ®Google Scholar
• Maes M, Kubera M, Obuchowiczwa E, Goehler L, Brzeszcz J. Depression's multiple co-morbidities explained by (neuro) inflammatory and oxidative & nitrosative stress pathways. Neuro Endocrinol Lett 2011;32:7–24.
   PubMed Web of Science ®Google Scholar
• Makki K, Froguel P, Wolowczuk I. Adipose tissue in obesity-related inflammation and insulin resistance: cells, cytokines, and chemokines. ISRN Inflamm 2013;22:139239.
   Google Scholar
• Yamout B, Alroughani R, Al-Jumah M, Khoury S, Abouzeid N, Dahdaleh M., et al. Consensus guidelines for the diagnosis and treatment of multiple sclerosis. Curr Med Res Opin 2013;29:611–21. doi: 10.1185/03007995.2013.787979
   PubMed Web of Science ®Google Scholar
• Flegal KM, Wei R, Ogden CL, Freedman DS, Johnson C, Curtin L. Characterizing extreme values of body mass index for age by using the 2000 Centers for Disease Control and Prevention growth charts. Am J Clin Nutr 2009;90:1314–20. doi: 10.3945/ajcn.2009.28335
   PubMed Web of Science ®Google Scholar
• Beck AT, Steer RA, Brown GK. Beck Depression Inventory, 2nd ed. San Antonio, TX: The Psychological Corporation; 1996.
   Google Scholar
• Beck AT, Steer RA, Garbin MG. Psychometric properties of the Beck Depression Inventory: twenty-five years of evaluation. Clin Psychol Rev 1988;8:77–100. doi: 10.1016/0272-7358(88)90050-5
   Web of Science ®Google Scholar
• Costa PT, McCrae RR. Professional manual for the revised NEO Personality Inventory and NEO Five-Factor Inventory. Odessa (Fla): Psychological Assessment Resources, Inc.; 1992.
   Google Scholar
• Caruso JC. Reliability generalization of the NEO personality scores. Educ Psychol Meas 2000;60:236–54. doi: 10.1177/00131640021970484
   Web of Science ®Google Scholar
• Chapman BP, Lyness JM, Duberstein P. Personality and medical illness burden among older adults in primary care. Psychosom Med 2007;69:277–82. doi: 10.1097/PSY.0b013e3180313975
   PubMed Web of Science ®Google Scholar
• Nettle D. The evolution of personality variation in humans and other animals. Am Psychol 2006;61:622–31. doi: 10.1037/0003-066X.61.6.622
   PubMed Web of Science ®Google Scholar
• Ware JE Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 1992;30:473–83. doi: 10.1097/00005650-199206000-00002
   PubMed Web of Science ®Google Scholar
• Ware JE, Snow KK, Kosinski M, Gandek B. SF-36 Health Survey: manual and interpretation guide. Boston, MA: New England Medical Center, The Health Institute; 1993.
   Google Scholar
• McHorney CA, Ware JE, Raczek AE. The MOS 36-item short-form health survey (SF-36). II. Psychometric and clinical tests of validity in measuring physical and mental health construct. Med Care 1993;31:247–63. doi: 10.1097/00005650-199303000-00006
   PubMed Web of Science ®Google Scholar
• Cella DF, Dineen K, Arnason B, Reder A, Webster KA, Karabatsos G, et al. Validation of the functional assessment of multiple sclerosis quality of life instrument. Neurology 1996;47:129–39. doi: 10.1212/WNL.47.1.129
   PubMed Web of Science ®Google Scholar
• Gruenewald DA, Higginson IJ, Vivat B, Edmonds P, Burman RE. Quality of life measures for the palliative care of people severely affected by multiple sclerosis: a systematic review. Mult Scler 2004;10:690–704. doi: 10.1191/1352458504ms1116rr
   PubMed Web of Science ®Google Scholar
• Fisk JD, Ritvo PG, Ross L, Haase DA, Marrie TJ, Schlech WF. Measuring the functional impact of fatigue: initial validation of the fatigue impact scale. Clin Infect Dis 1994;18:S79–83. doi: 10.1093/clinids/18.Supplement_1.S79
   PubMed Web of Science ®Google Scholar
• Mathiowetz V. Test-retest reliability and convergent validity of the Fatigue Impact Scale for persons with multiple sclerosis. Am J Occup Ther 2003;57:389–95. doi: 10.5014/ajot.57.4.389
   PubMed Web of Science ®Google Scholar
• Saka M, Saka M, Koseler E, Metin S, Bilen S, Aslanyavrusu M, et al. Nutritional status and anthropometric measurements of patients with multiple sclerosis. Saudi Med J 2012;33:160–66.
   PubMed Web of Science ®Google Scholar
• Pilutti LA, McAuley E, Motl RW. Weight status and disability in multiple sclerosis: an examination of bidirectional associations over a 24-month period. Mult Scler Relat Disord 2012;1:139–44. doi: 10.1016/j.msard.2012.02.004
   PubMed Web of Science ®Google Scholar
• Marrie RA, Horwitz RI. Emerging effects of comorbidities on multiple sclerosis. Lancet Neurol 2010;9:820–28. doi: 10.1016/S1474-4422(10)70135-6
   PubMed Web of Science ®Google Scholar
• Marrie RA, Chelune GJ, Miller DM, Cohen JA. Subjective cognitive complaints relate to mild impairment of cognition in multiple sclerosis. Mult Scler 2005;11:69–75. doi: 10.1191/1352458505ms1110oa
   PubMed Web of Science ®Google Scholar
• Soczynska JK, Kennedy SH, Woldeyohannes HO, Liauw SS, Alsuwaidan M, Yim CY, et al. Mood disorders and obesity: understanding inflammation as a pathophysiological nexus. Neuromolecular Med 2011;13:93–116. doi: 10.1007/s12017-010-8140-8
   PubMed Web of Science ®Google Scholar
• Esser N, Legrand-Poels S, Piette J, Scheen AJ, Paquot N. Inflammation as a link between obesity, metabolic syndrome and type 2 diabetes. Diabetes Res Clin Pract 2014;105:141–50. doi: 10.1016/j.diabres.2014.04.006
   PubMed Web of Science ®Google Scholar
• Sanoobar M, Eghtesadi S, Azimi A, Khalili M, Khodadadi B, Jazayeri S, et al. Coenzyme Q10 supplementation ameliorates inflammatory markers in patients with multiple sclerosis: a double blind, placebo, controlled randomized clinical trial. Nutr Neurosci 2015;18(4):169–76. doi: 10.1179/1476830513Y.0000000106
   PubMed Web of Science ®Google Scholar
• Lambert CP, Lee Archer R, Evans WJ. Body composition in ambulatory women with multiple sclerosis. Arch Phys Med Rehabil 2002;83:1559–61. doi: 10.1053/apmr.2002.35663
   PubMed Web of Science ®Google Scholar
• Hadgkiss EJ, Jelinek GA, Weiland TJ, Pereira NG, Marck CH, van der Meer DM. The association of diet with quality of life, disability, and relapse rate in an international sample of people with multiple sclerosis. Nutr Neurosci 2015;18(3):125–36. doi: 10.1179/1476830514Y.0000000117
   PubMed Web of Science ®Google Scholar
• Benedict RH, Wahlig EL, Topciu RA, Englert J, Schwartz E, Chapman B, et al. Personality traits in women with multiple sclerosis: discrepancy in patient/partner report and disease course. J Psychosom Res 2009;66:147–54. doi: 10.1016/j.jpsychores.2008.09.007
   PubMed Web of Science ®Google Scholar
• Benedict RH, Schwartz CE, Duberstein P, Healy B, Hoogs M, Bergsland N. Influence of personality on the relationship between gray matter volume and neuropsychiatric symptoms in multiple sclerosis. Psychosom Med 2013;75:253–61. doi: 10.1097/PSY.0b013e31828837cc
   PubMed Web of Science ®Google Scholar